Production (Stage)
CareRx Corporation
CRRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.40M | 65.85M | 68.07M | 67.21M | 66.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.40M | 65.85M | 68.07M | 67.21M | 66.55M |
| Cost of Revenue | 43.87M | 46.32M | 48.25M | 47.28M | 46.96M |
| Gross Profit | 18.53M | 19.53M | 19.82M | 19.93M | 19.60M |
| SG&A Expenses | 16.77M | 19.37M | 17.91M | 18.61M | 18.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.64M | 65.69M | 66.16M | 65.89M | 64.96M |
| Operating Income | 1.76M | 161.40K | 1.91M | 1.32M | 1.59M |
| Income Before Tax | 158.20K | -1.58M | -263.90K | -1.01M | -383.50K |
| Income Tax Expenses | -- | 22.90K | -- | -- | -- |
| Earnings from Continuing Operations | 158.20K | -1.60M | -263.90K | -1.01M | -383.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 158.20K | -1.60M | -263.90K | -1.01M | -383.50K |
| EBIT | 1.76M | 161.40K | 1.91M | 1.32M | 1.59M |
| EBITDA | 4.39M | 785.10K | 6.77M | 4.16M | 5.16M |
| EPS Basic | 0.00 | -0.03 | 0.00 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.03 | 0.00 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 62.73M | 60.93M | 60.09M | 60.13M | 59.86M |
| Average Diluted Shares Outstanding | 65.19M | 60.93M | 60.09M | 60.13M | 59.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |